According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is HK$37.40. In 2022 the company made an earnings per share (EPS) of HK$97.58 an increase over its 2021 EPS that were of -HK$168.73.
Year | EPS | Change |
---|---|---|
2023 (TTM) | HK$37.45 | -61.62% |
2022 | HK$97.58 | -157.83% |
2021 | -HK$168.73 | -35.22% |
2020 | -HK$260.48 | -5.63% |
2019 | -HK$276.03 | 20.34% |
2018 | -HK$229.38 | 55.26% |
2017 | -HK$147.74 | -19.15% |
2016 | -HK$182.73 | -6% |
2015 | -HK$194.39 | 42.86% |
2014 | -HK$136.07 | 52.17% |
2013 | -HK$89.42 | -41.03% |
2012 | -HK$151.62 | -93.62% |
2011 | -HK$2,378 | -65.57% |
2010 | -HK$6,905 | 88.66% |
2009 | -HK$3,660 | -32.78% |
2008 | -HK$5,445 | 16.59% |
2007 | -HK$4,670 | 26.96% |
2006 | -HK$3,679 | -11743.27% |
2005 | HK$31.60 | -101.88% |
2004 | -HK$1,680 | -554.77% |
2003 | HK$369.36 | 216.55% |
2002 | HK$116.68 | -85.01% |
2001 | HK$778.42 | 369.94% |
2000 | HK$165.64 | 404.51% |
1999 | HK$32.83 |